• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用首过灌注加权磁共振成像评估经动脉化疗栓塞术前、后肝细胞癌的血管情况。

Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging.

作者信息

Zhao Jun-Gong, Feng Gan-Sheng, Kong Xiang-Quan, Li Xin, Li Ming-Hua, Cheng Ying-Sheng

机构信息

Department of Radiology, Sixth Affiliated Hospital of Shanghai Jiaotong University, Shanghai 200233, China.

出版信息

World J Gastroenterol. 2004 Apr 15;10(8):1152-6. doi: 10.3748/wjg.v10.i8.1152.

DOI:10.3748/wjg.v10.i8.1152
PMID:15069716
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4656351/
Abstract

AIM

To assess the vascularity of hepatocellular carcinoma (HCC) before and after transcatheter arterial chemoembolization (TACE) with the quantitative parameters obtained by first pass perfusion weighted MR imaging (FP-MRI).

METHODS

Seventeen consecutive patients with one to three lesions in liver underwent FP-MRI before treatment. FP-MRI was also performed one, three, six, nine months, and one year after TACE. The baseline signal intensity (S0) of pre-TACE and one month after TACE was analyzed, the vascularity of HCC assessed by steepest slope of the signal intensity versus time curves (SS) was blindly correlated with their DSA feature and clinical outcome.

RESULT

No significant difference was found on baseline signal intensity (S0) between pre-TACE and one month after TACE (F=0.309, P=0.583), The SS (mean, 32% per second) of lesion one month after TACE was lower than that of pre-TACE (mean, 69% per second), but with no statistical significance (F=3.067, P=0.092). When local recurrence occurred, the time intensity curves became steeper. The vascularity of HCC before and after TACE graded by SS closely correlated with that by DSA (K=0.453, P<0.05).

CONCLUSION

FP-MRI is a useful criterion for selecting effective interventional treatment for patients with HCC in their initial treatment and during follow up.

摘要

目的

采用首次通过灌注加权磁共振成像(FP-MRI)获得的定量参数,评估经导管动脉化疗栓塞术(TACE)前后肝细胞癌(HCC)的血管情况。

方法

17例肝脏有1至3个病灶的连续患者在治疗前接受了FP-MRI检查。TACE术后1个月、3个月、6个月、9个月及1年也进行了FP-MRI检查。分析TACE术前及术后1个月的基线信号强度(S0),通过信号强度-时间曲线的最大斜率(SS)评估HCC的血管情况,并将其与DSA特征及临床结果进行盲法相关性分析。

结果

TACE术前与术后1个月的基线信号强度(S0)无显著差异(F = 0.309,P = 0.583),TACE术后1个月病灶的SS(平均每秒32%)低于术前(平均每秒69%),但无统计学意义(F = 3.067,P = 0.092)。当出现局部复发时,时间-强度曲线变得更陡。通过SS对TACE前后HCC血管情况的分级与DSA分级密切相关(K = 0.453,P < 0.05)。

结论

FP-MRI是为HCC患者在初始治疗及随访期间选择有效介入治疗的有用标准。

相似文献

1
Assessment of hepatocellular carcinoma vascularity before and after transcatheter arterial chemoembolization by using first pass perfusion weighted MR imaging.利用首过灌注加权磁共振成像评估经动脉化疗栓塞术前、后肝细胞癌的血管情况。
World J Gastroenterol. 2004 Apr 15;10(8):1152-6. doi: 10.3748/wjg.v10.i8.1152.
2
Image fusion with volume navigation of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) for post-interventional follow-up after transcatheter arterial chemoembolization (TACE) of hepatocellular carcinomas (HCC): Preliminary results.超声造影(CEUS)容积导航图像融合与计算机断层扫描(CT)或磁共振成像(MRI)在肝癌(HCC)经导管动脉化疗栓塞(TACE)后的介入后随访中的应用:初步结果。
Clin Hemorheol Microcirc. 2010;46(2-3):101-15. doi: 10.3233/CH-2010-1337.
3
Evaluating the therapeutic effect of hepatocellular carcinoma treated with transcatheter arterial chemoembolization by magnetic resonance perfusion imaging.评价磁共振灌注成像引导下经导管肝动脉化疗栓塞治疗肝细胞癌的疗效。
Eur J Gastroenterol Hepatol. 2014 Jan;26(1):109-13. doi: 10.1097/MEG.0b013e328363716e.
4
Changes of tumor microcirculation after transcatheter arterial chemoembolization: first pass perfusion MR imaging and Chinese ink casting in a rabbit model.经导管动脉化疗栓塞术后肿瘤微循环的变化:兔模型中的首过灌注磁共振成像及墨汁灌注法
World J Gastroenterol. 2004 May 15;10(10):1415-20. doi: 10.3748/wjg.v10.i10.1415.
5
Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation.经导管动脉内灌注:肝细胞癌化疗栓塞的磁共振监测——初步临床转化的可行性
Radiology. 2008 Mar;246(3):964-71. doi: 10.1148/radiol.2463070725.
6
Quantitative analysis of microcirculation blood perfusion in patients with hepatocellular carcinoma before and after transcatheter arterial chemoembolisation using contrast-enhanced ultrasound.使用超声造影对肝细胞癌患者经肝动脉化疗栓塞术前、后的微循环血流灌注进行定量分析。
Eur J Cancer. 2016 Nov;68:82-89. doi: 10.1016/j.ejca.2016.08.016. Epub 2016 Oct 10.
7
[Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].[经导管动脉化疗栓塞术治疗原发性肝细胞癌的磁共振扩散加权成像效果评估:25例患者4至6周随访]
Zhonghua Yi Xue Za Zhi. 2008 Sep 16;88(35):2474-7.
8
A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring.使用血管造影与经导管动脉内灌注/磁共振成像监测对化疗栓塞终点的比较。
J Vasc Interv Radiol. 2007 Oct;18(10):1249-57. doi: 10.1016/j.jvir.2007.06.028.
9
[Diagnostic value of computed tomographic perfusion imaging of whole liver for quantitative assessment of blood flow state in liver cancer after transcatheter arterial chemoembolization].全肝CT灌注成像对肝癌经导管动脉化疗栓塞术后肝脏血流状态定量评估的诊断价值
Zhonghua Gan Zang Bing Za Zhi. 2018 Jun 20;26(6):429-435. doi: 10.3760/cma.j.issn.1007-3418.2018.06.008.
10
Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion.经动脉化疗栓塞与手术/射频消融治疗伴或不伴微血管侵犯的复发性肝细胞癌。
J Gastroenterol Hepatol. 2014 May;29(5):1056-64. doi: 10.1111/jgh.12507.

引用本文的文献

1
Prognostic PET [C]-acetate uptake is associated with hypoxia gene expression in patients with late-stage hepatocellular carcinoma - a bench to bed study.晚期肝细胞癌患者预后 PET [C]-乙酸摄取与缺氧基因表达相关-一项从实验室到临床的研究。
Cancer Imaging. 2024 Mar 22;24(1):42. doi: 10.1186/s40644-024-00685-9.
2
Tumor Hypervascularity and hand-foot-skin reaction predict better outcomes in combination treatment of TACE and Sorafenib for intermediate hepatocellular carcinoma.肿瘤富血管化和手足皮肤反应预测索拉非尼联合 TACE 治疗中晚期肝癌有更好的疗效。
BMC Cancer. 2019 Apr 30;19(1):409. doi: 10.1186/s12885-019-5570-z.
3
11C-acetate and 18F-fluorodeoxyglucose positron emission tomography/computed tomography dual imaging for the prediction of response and prognosis after transarterial chemoembolization.11C-乙酸盐和18F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描双模态成像用于预测经动脉化疗栓塞后的反应和预后
Medicine (Baltimore). 2018 Sep;97(37):e12311. doi: 10.1097/MD.0000000000012311.
4
Advanced imaging techniques in the therapeutic response of transarterial chemoembolization for hepatocellular carcinoma.先进成像技术在肝细胞癌经动脉化疗栓塞治疗反应中的应用
World J Gastroenterol. 2016 May 28;22(20):4835-47. doi: 10.3748/wjg.v22.i20.4835.
5
Assessment of hemodynamics in precancerous lesion of hepatocellular carcinoma: evaluation with MR perfusion.肝细胞癌癌前病变的血流动力学评估:磁共振灌注成像评价
World J Gastroenterol. 2007 Feb 28;13(8):1182-6. doi: 10.3748/wjg.v13.i8.1182.

本文引用的文献

1
Comparison between chemoembolization combined with radiotherapy and chemoembolization alone for large hepatocellular carcinoma.化疗栓塞联合放疗与单纯化疗栓塞治疗大肝癌的比较。
World J Gastroenterol. 2003 Aug;9(8):1697-701. doi: 10.3748/wjg.v9.i8.1697.
2
[Mechanism of inhibition of tumor angiogenesis by Bletilla colloid: an experimental study].白及胶抑制肿瘤血管生成的机制:一项实验研究
Zhonghua Yi Xue Za Zhi. 2003 Mar 10;83(5):412-6.
3
Preventive treatments for recurrence after curative resection of hepatocellular carcinoma--a literature review of randomized control trials.肝细胞癌根治性切除术后复发的预防性治疗——随机对照试验的文献综述
World J Gastroenterol. 2003 Apr;9(4):635-40. doi: 10.3748/wjg.v9.i4.635.
4
[Helical dual-phase CT scan in evaluating blood supply of primary heptocellular carcinoma after transcatheter hepatic artery chemoembolization with lipiodol].[螺旋双期CT扫描在评价经肝动脉化疗栓塞联合碘油治疗后原发性肝癌血供中的应用]
Zhonghua Zhong Liu Za Zhi. 2003 Jan;25(1):82-4.
5
Supplemental transcatheter arterial chemoembolization through a collateral omental artery: treatment for hepatocellular carcinoma.经副支网膜动脉进行补充性经导管动脉化疗栓塞术:肝细胞癌的治疗方法
Cardiovasc Intervent Radiol. 2003 Mar-Apr;26(2):136-40. doi: 10.1007/s00270-002-2629-y. Epub 2003 Mar 18.
6
Vascularity of hepatic VX2 tumors of rabbits: assessment with conventional power Doppler US and contrast enhanced harmonic power Doppler US.兔肝VX2肿瘤的血管分布:传统能量多普勒超声与对比增强谐波能量多普勒超声评估
World J Gastroenterol. 2003 Feb;9(2):258-61. doi: 10.3748/wjg.v9.i2.258.
7
Application of poly-lactide-co-glycolide-microspheres in the transarterial chemoembolization in an animal model of hepatocellular carcinoma.聚乳酸-羟基乙酸共聚物微球在肝细胞癌动物模型经动脉化疗栓塞中的应用。
World J Gastroenterol. 2003 Jan;9(1):94-8. doi: 10.3748/wjg.v9.i1.94.
8
Hepatic arterial and portal venous phase helical CT in patients treated with transcatheter arterial chemoembolization for hepatocellular carcinoma: added value of unenhanced images.经动脉化疗栓塞治疗肝细胞癌患者的肝动脉期和门静脉期螺旋CT:平扫图像的附加价值
Radiology. 2002 Dec;225(3):773-80. doi: 10.1148/radiol.2253011346.
9
Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy.肝血流阻断下经皮射频消融治疗肝细胞癌患者。与标准经皮射频消融治疗的比较。
Cancer. 2002 Dec 1;95(11):2353-60. doi: 10.1002/cncr.10966.
10
Role and limitation of FMPSPGR dynamic contrast scanning in the follow-up of patients with hepatocellular carcinoma treated by TACE.FMPSPGR动态对比扫描在经肝动脉化疗栓塞术治疗的肝细胞癌患者随访中的作用及局限性
World J Gastroenterol. 2002 Aug;8(4):658-62. doi: 10.3748/wjg.v8.i4.658.